BRACCO VUEWAY 7.5ML VIAL 10/BX

Vueway? is indicated in adult and pediatric patients aged 2 years and older for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity in:

  • The central nervous system (brain, spine, and associated tissues).
  • The body (head and neck, thorax, abdomen, pelvis, and musculoskeletal system).

Related Products

GUERBET OPTIRAY 350 100ML VL 12/BX
97-133311A
GUERBET OPTIRAY 350 150ML VL 12/BX
97-133316A
GUERBET OPTIRAY 350 200ML VL 12/BX
97-133321A
GUERBET OPTIRAY 350 100ML PF 20/BX
97-133390A

BRACCO VUEWAY 7.5ML VIAL 10/BX: Enhance Medical Imaging Confidence in MRI

At Spectrum Medical Imaging Co., we recognize the importance of reliable contrast media in achieving precise diagnostic imaging. As a trusted contrast media supplier, we provide hospitals, outpatient centers, and radiology clinics with essential medical imaging supplies, including BRACCO VUEWAY 7.5ML VIAL 10/BX, a trusted leading gadolinium-based contrast agent for high-clarity Magnetic Resonance Imaging (MRI).

With over 40 years of experience, we support healthcare professionals with dependable products and full-spectrum medical imaging services, helping improve operational efficiency and patient care.

Diagnostic Imaging Confidence with BRACCO VUEWAY 7.5 ML Vials

Clear, high-resolution images are essential for confident, accurate interpretation in medical imaging. BRACCO VUEWAY, containing gadopiclenol, is formulated to enhance visualization across a broad range of MRI applications, helping healthcare professionals detect and assess representative lesions during every imaging exam.

  • Designed for High-Precision MRI Procedures: Ideal for imaging the central nervous system (brain, spine), soft tissue, and vascular structures, VUEWAY supports detailed anatomical evaluation and improves lesion visibility.
  • Improves Concordance in Lesion Detectability: The contrast enhancement provided by VUEWAY contributes to more consistent and accurate lesion identification, enhancing diagnostic confidence for radiologists and imaging teams.
  • Clinically Proven Macrocyclic Gadolinium-Based Contrast Agent: As a macrocyclic gadolinium-based contrast agent, VUEWAY offers stability and safety. Its proven performance in clinical studies reinforces its value in advanced MRI protocols.

 

With its advanced formulation and dependable performance, BRACCO VUEWAY 7.5ML VIAL empowers imaging teams to achieve consistent, high-quality results and support accurate diagnoses across a variety of medical imaging settings.

VUEWAY’s 7.5ML Format – Versatility and Efficiency in One

In high-demand medical imaging environments, efficiency and accuracy are essential. The BRACCO VUEWAY 7.5ML VIAL 10/BX format, developed by Bracco Imaging, is designed to support streamlined medical imaging services for both adult and pediatric patients (ages 2 and up) undergoing Magnetic Resonance Imaging (MRI).

This formulation integrates smoothly into daily workflows involving intravenous injection and enhances operational consistency in diagnostic settings.

  • Convenient Volume for Flexible Dosing: The 7.5mL vial supports individualized dosing based on patient weight and imaging protocol. This flexibility helps reduce waste, improves dose precision during intravenous administration, and is especially effective in aligning with the needs of patients at risk or undergoing complex imaging exams.
  • Optimized for Imaging Centers and Radiology Departments: The 10-vial pack format enables efficient inventory control, making it easier for healthcare providers and healthcare professionals to maintain consistent access to essential medical imaging supplies in fast-paced environments such as radiology clinics and imaging centers.
  • Supports Diagnostic Accuracy and Workflow Consistency: As a stable, macrocyclic gadolinium-based contrast agent, VUEWAY enhances the visualization of representative lesions throughout the human body, improving concordance in lesion detectability. Backed by clinical studies and laboratory testing, it supports precise, confident interpretation in diagnostic imaging.
  • Trusted Contrast Media for Safer MRI Use: Developed for use in patients undergoing MRI, VUEWAY minimizes potential risk and is less likely to cause injection site reactions. It is suitable for use in individuals with concerns related to gadolinium-containing contrast agents, and has a favorable safety profile supported by gadolinium-based contrast media research.

 

As a leading contrast media supplier, Spectrum Medical Imaging Co. ensures that facilities can access trusted products like BRACCO VUEWAY alongside expert support in contrast media in radiology, nuclear medicine exclusions, and ongoing imaging workflow optimization.

Trusted Supply from Spectrum Medical Imaging Co.

Accessing essential contrast media like BRACCO VUEWAY reliably is crucial for uninterrupted patient care. Spectrum Medical Imaging Co. is your trusted contrast media supplier, providing dependable access to Bracco imaging products along with comprehensive support for your medical imaging needs.

We leverage over 40 years of industry experience and established manufacturer relationships to secure preferential pricing, offering a Best Price guarantee to beat competitor pricing. Our commitment to efficiency includes fast, nationwide shipping within 24-48 hours, ensuring you receive your BRACCO VUEWAY 7.5ML VIAL 10/BX supply promptly.

Request Pricing from a Trusted Contrast Media Supplier

Looking to enhance your diagnostic imaging workflow with BRACCO VUEWAY 7.5ML VIAL 10/BX? As a reliable contrast media supplier, Spectrum Medical Imaging Co. provides fast access to high-quality contrast agents, along with expert contrast injector repair and maintenance services to support your imaging operations.

Contact our sales team today to request pricing, check availability, or place an order. Let us help you streamline procurement and maintain uninterrupted access to essential medical imaging supplies.

Frequently Asked Questions

Q1. Can BRACCO VUEWAY increase the risk of contrast-induced acute kidney injury?

While contrast-induced acute kidney injury is a concern with certain agents, BRACCO VUEWAY has demonstrated a favorable safety profile in clinical use. High-risk patients, including those with pre-existing renal impairment, should be assessed carefully. Healthcare providers should follow established protocols to minimize risk and ensure safe use of gadolinium-based contrast agents.

Q2. What types of adverse reactions are associated with VUEWAY?

Like other gadolinium-based agents, adverse reactions to VUEWAY are generally mild and may include headache, nausea, or local injection site irritation. Allergic reactions and rare severe reactions such as anaphylaxis have been reported, though infrequently. Screening patients for known reactions to gadolinium and other allergens is essential to ensure safety during administration.

Q3. How does BRACCO VUEWAY support accurate diagnosis?

BRACCO VUEWAY is formulated to deliver detailed images and high lesion visibility by enhancing abnormal vascularity and soft tissue contrast. This clarity supports accurate diagnosis, particularly in studies involving the blood vessels, brain, spine, and other critical structures, contributing directly to improved patient diagnosis outcomes.

Q4. Is BRACCO VUEWAY compatible with standard medical imaging equipment?

Yes, VUEWAY is designed for use with most modern medical imaging equipment used in Magnetic Resonance Imaging (MRI). It integrates seamlessly into current imaging workflows and protocols, allowing radiology teams to maintain high diagnostic quality without requiring adjustments to their MRI systems.